LEADER 01797nam  2200505I  450 
001 9910703892403321
005 20150624160431.0
035   $a(CKB)5470000002434803
035   $a(OCoLC)911531329
035   $a(EXLCZ)995470000002434803
100   $a20150624d1987      ua             0
101 0 $aeng
135   $aurbn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aEvaluation of the endogenous glucocorticoid hypothesis of denervation atrophy /$fMasaaki Konagaya, Yoko Konagaya and Stephen R. Max
205   $aRevised.
210  1$aBaltimore, MD :$cDepartment of Neurology, University of Maryland School of Medicine,$d[1987].
215   $a1 online resource (10 pages, 2 unnumbered pages)
225 1 $aNASA CR ;$v182848
300   $aTitle from title screen (viewed on June 24, 2015).
320   $aIncludes bibliographical references (pages 7-10).
606   $aAtrophy$2nasat
606   $aCorticosteroids$2nasat
606   $aNeuromuscular transmission$2nasat
606   $aGlutamine$2nasat
606   $aMuscular tonus$2nasat
615  7$aAtrophy.
615  7$aCorticosteroids.
615  7$aNeuromuscular transmission.
615  7$aGlutamine.
615  7$aMuscular tonus.
700   $aKonagaya$b Masaaki$01396339
702   $aKonagaya$b Yoko
702   $aMax$b Stephen R.
712 02$aUniversity of Maryland at Baltimore.$bDepartment of Neurology,
712 02$aUnited States.$bNational Aeronautics and Space Administration,
712 02$aNational Institutes of Health (U.S.),
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910703892403321
996   $aEvaluation of the endogenous glucocorticoid hypothesis of denervation atrophy$93456315
997   $aUNINA